Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTsSabrina Rossi, Daniela Gasparotto, Matilde Cacciatore, et al.NPJ Precision Oncology|January 20, 2026
KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GISTSimona Gloazzo, Marta Sbaraglia, Elena Bellan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2008
Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entityDaniela Gasparotto, Sabrina Rossi, Italo Bearzi, et al.Iscience|June 22, 2026
An integrated patient-derived colon organoids platform as a functional model for nutraceutical and stress responseAngelita Costantino, Paolo Giuseppe Bonacci, Giulia Zerbo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2012
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomasDebora Martorelli, Massimo Guidoboni, Valli De Re, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 SyndromeDaniela Gasparotto, Sabrina Rossi, Maurizio Polano, et al.Oncotarget|April 21, 2016
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsSabrina Rossi, Marta Sbaraglia, Marta Campo Dell'Orto, et al.The American Journal of Surgical Pathology|September 24, 2010
Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small sizeSabrina Rossi, Daniela Gasparotto, Luisa Toffolatti, et al.The American Journal of Surgical Pathology|May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based studySabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.Scientific Data|November 10, 2021
Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark studyYongmei Zhao, Li Tai Fang, Tsai-Wei Shen, et al.Pageof 4